Emami Group
Have updates for this profile? Please contribute data
= Subscriber Access Only
You are viewing a preview of this profile. Request a Preqin Pro demo for full access to all profiles and underlying data.
With Preqin Pro, you gain an unobstructed view of all alternative asset class activity across institutional investors, fund managers, funds, portfolio companies, deals, exits, and service providers.
Emami Group - overview
Established
1906
Location
Kolkata, -, India
Primary Industry
Healthcare
About
Emami Group is a diversified conglomerate engaged in fast-moving consumer goods, real estate, and specialty manufacturing, catering to a broad spectrum of consumer needs across health and beauty sectors. Emami Group, founded in 1906 and headquartered in Kolkata, India, operates primarily in FMCG, real estate, and specialty manufacturing. The company does not have known subsidiaries or significant pivots in business strategy. The founders have successfully built a portfolio that addresses diverse consumer demands.
The current leadership includes Chandra Katiyar, Naresh Bhansali, and Punita Kalra. Emami Group is primarily focused on the fast-moving consumer goods (FMCG) sector, real estate, and specialty manufacturing. Its flagship company, Emami Limited, provides a comprehensive array of beauty and healthcare products, emphasizing personal care and wellness. The product portfolio encompasses well-known brands in skincare, haircare, and over-the-counter healthcare solutions, making it accessible to both urban and rural markets across India and internationally, including regions in Africa and the Middle East.
Emami Agrotech Limited is involved in branded food manufacturing, specifically edible oils and biodiesel, while Emami Paper Mills Limited focuses on producing newsprint and packaging board, serving global publishers and packaging companies. Other business segments include retail pharmacy through Emami Frank Ross Limited and contemporary art curation via Emami Art, catering to art collectors in urban centers. Emami Group reported a revenue of ₹27,000 Crores in 2023, supported by a robust B2B and B2C structure. Revenue generation is bolstered by flagship products sold through various channels, such as retailer partnerships and direct sales.
The FMCG division utilizes promotional campaigns and bulk purchasing agreements, ensuring broad distribution and consumer engagement. The pharmacy division operates over 250 pharmacies, enhancing sales opportunities, while Emami's retail operations leverage both physical and online platforms to maximize reach.
Primary Industry
Healthcare
Sub Industries
Aesthetic Medicine, Crop Production
Website
www.emamigroup.com
Verticals
E-commerce, Manufacturing
Total Amount Raised
Subscriber access only
Emami Group - deals
| Deals Type | Deal Status | Target (s) | Deal Date | Investor(s) | Seller(s) | Deal size (Mn) | Enterprise value (Mn) | Post-money valuation (Mn) | EBITDA multiple (x) | Revenue multiple (x) | Lead partner (s) |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Add-on | Completed | AMRI Hospitals Limited | - | ||||||||
| PIPE | Completed | Emami Ltd | - |
Displaying 1 - 2 of 2

Time to go Pro
Get Preqin Pro for unrestricted access to 600,000+ detailed profiles on fund managers, investors, funds, companies, and other alternative asset players. Unlock exclusive data on future plans, company financials, fundraising history, track records, and more.